Holen Sie sich die Stockscreener-App
18.76
2.44%
-0.47
Handel nachbörslich:
18.74
-0.02
-0.11%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$19.23
Offen:
$19.1
24-Stunden-Volumen:
19.47M
Relative Volume:
0.99
Marktkapitalisierung:
$36.02B
Einnahmen:
$15.29B
Nettoeinkommen (Verlust:
$1.62B
KGV:
22.25
EPS:
0.8433
Netto-Cashflow:
$1.82B
1W Leistung:
-5.16%
1M Leistung:
+3.42%
6M Leistung:
+9.58%
1J Leistung:
-14.02%
1-Tages-Spanne:
$18.71
$19.25
1-Wochen-Bereich:
$18.71
$19.86
52-Wochen-Spanne:
$14.02
$22.87
Kenvue Inc Stock (KVUE) Company Profile
Firmenname
Kenvue Inc
Sektor
Telefon
908-874-1200
Adresse
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, KMB
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
18.76 | 36.92B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
146.08 | 345.49B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
60.84 | 132.38B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
91.03 | 74.59B | 20.80B | 2.22B | 3.77B | 2.5772 |
KMB
Kimberly Clark Corp
|
106.82 | 36.57B | 16.56B | 1.75B | 1.84B | 6.36 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-30 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-29 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | Eingeleitet | Redburn Atlantic | Neutral |
| 2025-03-24 | Eingeleitet | Evercore ISI | In-line |
| 2025-01-06 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-09-24 | Eingeleitet | Jefferies | Buy |
| 2024-09-24 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | Fortgesetzt | Citigroup | Neutral |
| 2024-04-11 | Eingeleitet | Bernstein | Underperform |
| 2024-04-03 | Eingeleitet | William Blair | Mkt Perform |
| 2024-03-01 | Fortgesetzt | Goldman | Neutral |
| 2023-11-17 | Eingeleitet | Piper Sandler | Neutral |
| 2023-09-11 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-09-07 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-09-06 | Eingeleitet | Argus | Hold |
| 2023-08-24 | Hochstufung | Goldman | Neutral → Buy |
| 2023-07-25 | Eingeleitet | Edward Jones | Buy |
| 2023-06-01 | Eingeleitet | HSBC Securities | Hold |
| 2023-05-30 | Eingeleitet | BofA Securities | Buy |
| 2023-05-30 | Eingeleitet | Citigroup | Neutral |
| 2023-05-30 | Eingeleitet | Deutsche Bank | Hold |
| 2023-05-30 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2023-05-30 | Eingeleitet | Goldman | Neutral |
| 2023-05-30 | Eingeleitet | JP Morgan | Overweight |
| 2023-05-30 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-05-30 | Eingeleitet | UBS | Neutral |
Alle ansehen
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Calamos Advisors LLC Acquires 651,000 Shares of Kenvue Inc. $KVUE - MarketBeat
Listerine Cool Mint by Kenvuemouthwash classic with cool focus - Ad-hoc-news.de
Kenvue/Kimberly-Clark Deal Not in Jeopardy Despite Tylenol Ruling -- Market Talk - Moomoo
Kenvue Inc. stock falls Monday, underperforms market - MarketWatch
Second Circuit Court of Appeals Ruling - Kenvue
Kenvue's Tylenol Liability Nightmare: Appeals Court Reversal Ignites Fresh Legal Battle - Kavout | AI
U.S. appeals court revives more than 500 lawsuits against Tylenol-maker Kenvue over autism claims - The Globe and Mail
Update: Kenvue Must Face Claims Linking Tylenol to Autism, Appeals Court Says - Moomoo
US appeals court revives hundreds of private lawsuits linking Tylenol to autism - Reuters
KVUE Stock Dips After Court Revives Tylenol Autism Lawsuits - Stocktwits
Tylenol-Maker Kenvue Must Face Autism Lawsuits, Court Says - Bloomberg.com
Tylenol-Maker Kenvue Must Face Autism Lawsuits, Court Says (2) - Bloomberg Law News
Kenvue (KVUE) Shares Surge After Favorable Court Ruling - GuruFocus
Kenvue options trading climbs to over 16,000 contracts By Investing.com - Investing.com Australia
Kenvue options trading climbs to over 16,000 contracts - Investing.com UK
Kenvue stock falls after court revives autism lawsuits By Investing.com - Investing.com Nigeria
Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
US Appeals court revives lawsuits linking Tylenol-maker Kenvue to autism (update) (KVUE:NYSE) - Seeking Alpha
Kenvue stock falls after court revives autism lawsuits - Investing.com
Listerine Cool Mint by Kenvue Inc.mouthwash staple under fresh brand owner - Ad-hoc-news.de
Kenvue stock steadies as investors weigh its consumer brands - Ad-hoc-news.de
Billionaire Ken Griffin Boosted His Stake in This Dividend King by 146%. Here's Why It's a Dream Stock for Risk-Averse Investors. - The Motley Fool
Kenvue (NYSE:KVUE) Rating Increased to Buy at Wall Street Zen - MarketBeat
Kenvue stock holds steady as consumer health portfolio underpins long-term growth - Ad-hoc-news.de
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Sumitomo Mitsui Trust Group Inc. Sells 343,749 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady as the consumer health story builds - Ad-hoc-news.de
Kenvue's Hidden Bullish Bet: Options Surge Amidst Acquisition and Mixed Valuation Signals - Kavout | AI
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Illinois Appellate Court Affirms $45 Million Mesothelioma Verdict Against Johnson & Johnson and Kenvue - Caledonian Record
Kenvue options trading jumps with calls dominating activity By Investing.com - Investing.com Australia
Traders Buy Large Volume of Kenvue Call Options (NYSE:KVUE) - MarketBeat
Kenvue options trading jumps with calls dominating activity - Investing.com UK
Top Kenvue (KVUE) Competitors 2026 - MarketBeat
Kenvue (NYSE:KVUE) Stock Rating Lowered by Zacks Research - MarketBeat
Greenwood Capital Associates LLC Purchases 56,326 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Wednesday, underperforms market - MarketWatch
Kimberly-Clark tops indexes as Kenvue deal nears - MSN
Kenvue reduces virgin plastic use as part of sustainability efforts - Plastics News
Swedbank AB Increases Stake in Kenvue Inc. $KVUE - MarketBeat
Kenvue steadies its post-spin strategy as consumer health demand stays resilient - ad-hoc-news.de
Kenvue Inc. stock rises Tuesday, outperforms market - MarketWatch
3 Dirt Cheap Healthcare Shares Under $30 to Buy Right Now - 24/7 Wall St.
Kenvue Inc. $KVUE is Credit Industriel ET Commercial's 9th Largest Position - MarketBeat
Tylenol Extra Strength Caplets from Kenvue Inc.popular US pain relief workhorse - AD HOC NEWS
Kenvue stock holds its ground. Investors wait for a fresh catalyst. - AD HOC NEWS
HSBC Adjusts Price Target on Kenvue to $20 From $19 - Moomoo
Kenvue stock keeps the focus on its consumer brands - AD HOC NEWS
Kenvue surpasses 2025 plastic reduction target, falls short on recyclability - Supply Chain Dive
Buffalo Growth & Income Fund's Kenvue Inc(KVUE) Holding History - GuruFocus
Hsbc Holdings PLC Has $88.23 Million Stock Position in Kenvue Inc. $KVUE - MarketBeat
Finanzdaten der Kenvue Inc-Aktie (KVUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):